Leukocyte gene expression in patients with medication refractory depression before and after treatment with ECT or isoflurane anesthesia: A pilot study

Depression Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Iacob, E ^a   Tadler, S C ^a   Light, K C ^a   Weeks, H R ^a,b   Smith, K W ^a   White, A T ^a,c   Hughen, R W ^a   Vanhaitsma, T A ^c   Bushnell, L A ^b   Light, A R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900295600     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2014/582380     Document Type: Article

References (81)

1. Cattaneo A., Gennarelli M., Uher R., Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline "predictors" and longitudinal 'targets'. Neuropsychopharmacology 2013 38 2 377 385
2. Le-Niculescu H., Leveyet D. F., Ayalewal M., Discovery and validation of blood biomarkers for suicidality. Molecular Psychiatry 2013 18 1249 1264
3. Rush A. J., Trivedi M. H., Wisniewski S. R., Nierenberg A. A., Stewart J. W., Warden D., Niederehe G., Thase M. E., Lavori P. W., Lebowitz B. D., McGrath P. J., Rosenbaum J. F., Sackeim H. A., Kupfer D. J., Luther J., Fava M., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report. American Journal of Psychiatry 2006 163 11 1905 1917 2-s2.0-33751338530 10.1176/appi.ajp.163.11.1905 (Pubitemid 44807782)
4. Prudic J., Haskett R. F., Mulsant B., Malone K. M., Pettinati H. M., Stephens S., Greenberg R., Rifas S. L., Sackeim H. A., Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry 1996 153 8 985 992 2-s2.0-0029836080 (Pubitemid 26264697)
5. Khalid N., Atkins M., Tredget J., Giles M., Champney-Smith K., Kirov G., The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study. Journal of ECT 2008 24 2 141 145 2-s2.0-54049131428 10.1097/YCT.0b013e318157ac58
6. Geddes J., Carney S., Cowen P., Goodwin G., Rogers R., Dearness K., Tomlin A., Eastaugh J., Freemantle N., Lester H., Harvey A., Scott A., Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet 2003 361 9360 799 808 2-s2.0-0037426064 10.1016/S0140-6736(03)12705-5 (Pubitemid 36331841)
7. Semkovska M., McLoughlin D. M., Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry 2010 68 6 568 577 2-s2.0-77956177858 10.1016/j.biopsych.2010.06.009
8. Dunne R. A., McLoughlin D. M., Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World Journal of Biological Psychiatry 2012 13 4 248 258 2-s2.0-84860446253 10.3109/15622975.2011.615863
9. Langer G., Neumark J., Koinig G., Rapid psychotherapeutic effects of anesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients. Neuropsychobiology 1985 14 3 118 120 2-s2.0-0022338962 (Pubitemid 16154548)
10. Langer G., Karazman R., Neumark J., Saletu B., Schonbeck G., Gronberger J., Dittrich R., Petricek W., Hoffmann P., Linzmayer L., Anderes P., Steinberger K., Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment. A double-blind comparison with electroconvulsive treatment. Neuropsychobiology 1995 31 4 182 194 2-s2.0-0029003126
11. Carl C., Engelhardt W., Teichmann G., Fuchs G., Open comparative study with treatment-refractory depressed patients: electroconvulsive therapy-anesthetic therapy with isoflurane (preliminary report). Pharmacopsychiatry 1988 21 6 432 433 2-s2.0-0024213747 (Pubitemid 19024214)
12. Engelhardt W., Carl G., Hartung E., Intra-individual open comparison of burst-suppression-isoflurane-anaesthesia versus electroconvulsive therapy in the treatment of severe depression. European Journal of Anaesthesiology 1993 10 2 113 118 2-s2.0-0027159289 (Pubitemid 23128235)
13. Greenberg L. B., Gage J., Vitkun S., Fink M., Isoflurane anesthesia therapy: a replacement for ECT in depressive disorders? Convulsive Therapy 1987 3 4 269 277 2-s2.0-0023489282 (Pubitemid 18004989)
14. García-Toro M., Segura C., González A., Perelló J., Valdivia J., Salazar R., Tarancón G., Campoamor F., Salva J., De La Fuente L., Romera M., Inefficacy of burst-suppression anesthesia in medication-resistant major depression: a controlled trial. Journal of ECT 2001 17 4 284 288 2-s2.0-20244367729 10.1097/00124509-200112000-00009 (Pubitemid 33131311)
15. Weeks H. R., Tadler S. C., Smith K. W., Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression. PLoS ONE 2013 8 7 1 8
16. Iga J.-I., Ueno S.-I., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., Nakataki M., Song H., Hokoishi K., Tanabe H., Sano A., Ohmori T., Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 31 3 658 663 2-s2.0-33947584638 10.1016/j.pnpbp.2006. 12.011 (Pubitemid 46476822)
17. Light A. R., White A. T., Hughen R. W., Light K. C., Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. Journal of Pain 2009 10 10 1099 1112 2-s2.0-70349443514 10.1016/j.jpain.2009.06.003
18. Light K. C., Genetics and gene expression involving stress and distress pathways in fibromyalgia with and without comorbid chronic fatigue syndrome. Pain Research and Treatment 2012 2012 13 10.1155/2012/427869 427869
19. Coryell M. W., Wunsch A. M., Haenfler J. M., Allen J. E., Schnizler M., Ziemann A. E., Cook M. N., Dunning J. P., Price M. P., Rainier J. D., Liu Z., Light A. R., Langbehn D. R., Wemmie J. A., Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. Journal of Neuroscience 2009 29 17 5381 5388 2-s2.0-65649108552 10.1523/JNEUROSCI.0360-09. 2009
20. Smolin B., Karry R., Gal-Ben-Ari S., Ben-Shachar D., Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology. International Journal of Neuropsychopharmacology 2012 15 7 869 882
21. Wu W.-L., Lin Y.-W., Min M.-Y., Chen C.-C., Mice lacking Asic3 show reduced anxiety-like behavior on the elevated plus maze and reduced aggression. Genes, Brain and Behavior 2010 9 6 603 614 2-s2.0-77955144561 10.1111/j.1601-183X.2010.00591.x
22. American Psychiatric Association, Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC, USA, American Psychiatric Association, 2000
23. Hamilton M., A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960 23 56 62 2-s2.0-72949151592
24. Hamilton M., Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 1967 6 4 278 296 2-s2.0-0014186152
25. Rush A. J., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 2003 54 5 573 583 (Pubitemid 37289444)
26. Nibuya M., Morinobu S., Duman R. S., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995 15 11 7539 7547 2-s2.0-0028815653
27. Madsen T. M., Treschow A., Bengzon J., Bolwig T. G., Lindvall O., Tingström A., Increased neurogenesis in a model of electroconvulsive therapy. Biological Psychiatry 2000 47 12 1043 1049 2-s2.0-0034040357 10.1016/S0006-3223(00)00228-6 (Pubitemid 30336212)
28. Stelzhammer V., Guest P. C., Rothermundt M., Sondermann C., Michael N., Schwarz E., Rahmoune H., Bahn S., Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. European Neuropsychopharmacology 2013 23 10 1199 1207 10.1016/j.euroneuro.2012.10.012
29. Mathé A. A., Neuropeptides and electroconvulsive treatment. Journal of ECT 1999 15 1 60 75 2-s2.0-0032982595 (Pubitemid 29318094)
30. Okabe T., Sato C., Matsumoto K., Ozawa H., Sakamoto A., Electroconvulsive stimulation (ECS) increases the expression of neuropeptide Y (NPY) in rat brains in a model of neuropathic pain: a quantitative real-time polymerase chain reaction (RT-PCR) study. Pain Medicine 2009 10 8 1460 1467
31. Sackeim H. A., The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. Journal of ECT 1999 15 1 5 26 2-s2.0-0032983033 (Pubitemid 29318091)
32. Li L., Deng J., Zuo Z., Glutamate transporter type 3 mediates isoflurane preconditioning-induced acute phase of neuroprotection in mice. Brain Research Bulletin 2013 98 23 29
33. Kranaster L., Plum P., Hoyer C., Sartorius A., Ullrich H., Burst suppression: a more valid marker of postictal central inhibition? Journal of ECT 2013 29 1 25 28 10.1097/YCT.0b013e3182801cce
34. Murrell J. C., Waters D., Johnson C. B., Comparative effects of halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram of the rat. Laboratory Animals 2008 42 2 161 170 2-s2.0-44649100161 10.1258/la.2007.06019e (Pubitemid 351786019)
35. Wang L., Elmer G. I., Mayo C. L., Gould T. D., Shepard P. D., Isoflurane impedes the development of a depression-like phenotype in rats. Proceedings of the Society for Neuroscience Annual Meeting Planner 2012
36. Miller A. H., Maletic V., Raison C. L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009 65 9 732 741 2-s2.0-63449122724 10.1016/j.biopsych.2008.11.029
37. Belzeaux R., Formisano-Tréziny C., Loundou A., Boyer L., Gabert J., Samuelian J.-C., Féron F., Naudin J., Ibrahim E. C., Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. Journal of Psychiatric Research 2010 44 16 1205 1213 2-s2.0-78649703964 10.1016/j.jpsychires.2010.04.011
38. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E. K., Lanctôt K. L., A meta-analysis of cytokines in major depression. Biological Psychiatry 2010 67 5 446 457 2-s2.0-75849155537 10.1016/j.biopsych. 2009.09.033
39. Rotter A., Teresa B., Christiane S., Changes of cytokine profiles during electroconvulsive therapy in patients with major depression. Journal of ECT 2013 29 3 162 169 10.1097/YCT.0b013e3182843942
40. Fluitman S. B. A. H. A., Heijnen C. J., Denys D. A. J. P., Nolen W. A., Balk F. J., Westenberg H. G. M., Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. Journal of Affective Disorders 2011 131 1-3 388 392 2-s2.0-79955916722 10.1016/j.jad.2010.11.035
41. Belvederi Murri M., Pariante C. M., Dazzan P., Hepgul N., Papadopoulos A. S., Zunszain P., Di Forti M., Murray R. M., Mondelli V., Hypothalamic- pituitary-adrenal axis and clinical symptoms in first-episode psychosis. Psychoneuroendocrinology 2012 37 5 629 644 2-s2.0-84858440001 10.1016/j.psyneuen.2011.08.013
42. Iacob E., Light K. C., Tadler S. C., Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls. BMC Psychiatry 2013 13, article 273
43. Anacker C., Zunszain P. A., Carvalho L. A., Pariante C. M., The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011 36 3 415 425 2-s2.0-79951956849 10.1016/j.psyneuen.2010.03.007
44. Hageman I., Nielsen M., Wortwein G., Diemer N. H., Jorgensen M. B., Electroconvulsive stimulations normalizes stress-induced changes in the glucocorticoid receptor and behaviour. Behavioural Brain Research 2009 196 1 71 77 2-s2.0-56549118097 10.1016/j.bbr.2008.07.037
45. Yuuki N., Ida I., Oshima A., Kumano H., Takahashi K., Fukuda M., Oriuchi N., Endo K., Matsuda H., Mikuni M., HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatrica Scandinavica 2005 112 4 257 265 2-s2.0-25644438454 10.1111/j.1600-0447.2005. 00625.x (Pubitemid 41382731)
46. Basu S., Dasgupta P. S., Dopamine, a neurotransmitter, influences the immune system. Journal of Neuroimmunology 2000 102 2 113 124 2-s2.0-0033992334 10.1016/S0165-5728(99)00176-9
47. Fosse R., Read J., Electroconvulsive treatment: hypotheses about mechanisms of action. Frontiers in Psychiatry 2013 4, article 94
48. Adachi Y. U., Yamada S., Satomoto M., Higuchi H., Watanabe K., Kazama T., Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum. Brain Research Bulletin 2005 67 3 176 181 2-s2.0-24144489716 10.1016/j.brainresbull.2005.06.020 (Pubitemid 41242921)
49. Adachi Y. U., Yamada S., Satomoto M., Higuchi H., Watanabe K., Kazama T., Mimuro S., Sato S., Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study. Neurochemistry International 2008 52 3 384 391 2-s2.0-38049005347 10.1016/j.neuint.2007.07.012
50. Rocc P., de Leo C., Eva C., Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2002 26 6 1155 1160 10.1016/S0278-5846(02)00253-1 (Pubitemid 35256109)
51. Stefanis N. C., Bresnick J. N., Kerwin R. W., Schofield W. N., McAllister G., Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Molecular Brain Research 1998 53 1-2 112 119 2-s2.0-0031602301 10.1016/S0169-328X(97)00285-4 (Pubitemid 28085447)
52. Xiang L., Szebeni K., Szebeni A., Klimek V., Stockmeier C. A., Karolewicz B., Kalbfleisch J., Ordway G. A., Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression. Brain Research 2008 1207 214 224 2-s2.0-41949133970 10.1016/j.brainres.2008.02.009
53. Meyer J. H., Krüger S., Wilson A. A., Christensen B. K., Goulding V. S., Schaffer A., Minifie C., Houle S., Hussey D., Kennedy S. H., Lower dopamine transporter binding potential in striatum during depression. NeuroReport 2001 12 18 4121 4125 2-s2.0-0035930464 (Pubitemid 33152464)
54. Vogel M., Pfeifer S., Schaub R. T., Grabe H.-J., Barnow S., Freyberger H. J., Cascorbi I., Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology 2004 50 4 305 310 2-s2.0-8344233544 10.1159/000080958 (Pubitemid 39482670)
55. Coughtrie M. W. H., Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics Journal 2002 2 5 297 308 2-s2.0-0036448454 10.1038/sj.tpj.6500117 (Pubitemid 35439472)
56. Pasqualini J. R., Estrogen sulfotransferases in breast and endometrial cancers. Annals of the New York Academy of Sciences 2009 1155 88 98 2-s2.0-61649104578 10.1111/j.1749-6632.2009.04113.x
57. Marazziti D., Palego L., Dell'Osso L., Batistini A., Cassano G. B., Akiskal H. S., Platelet sulfotransferase in different psychiatric disorders. Psychiatry Research 1996 65 2 73 78 2-s2.0-0030588665 10.1016/S0165-1781(96) 02898-3 (Pubitemid 27050692)
58. Corda M. G., Ferrari M., Guidotti A., Isolation, purification and partial sequence of a neuropeptide (diazepam-binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site. Neuroscience Letters 1984 47 3 319 324 2-s2.0-0021249393 10.1016/0304-3940(84)90533-0 (Pubitemid 14081906)
59. Barbaccia M. L., Costa E., Ferrero P., Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid. Studies in depression, schizophrenia, and Alzheimer's disease. Archives of General Psychiatry 1986 43 12 1143 1147 2-s2.0-0022998560 (Pubitemid 17184444)
60. Tsao C.-W., Lin Y.-S., Chen C.-C., Bai C.-H., Wu S.-R., Cytokines and serotonin transporter in patients with major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006 30 5 899 905 2-s2.0-33646904326 10.1016/j.pnpbp.2006.01.029 (Pubitemid 43795377)
61. Barbaccia M. L., Much excitement about antidepressants, DBI and c-FOS. Pharmacological Research 2011 64 4 333 335 2-s2.0-80052970597 10.1016/j.phrs.2011.05.018
62. Roy A., Pickar D., Gold P., Barbaccia M., Guidotti A., Costa E., Linnoila M., Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid. Acta Psychiatrica Scandinavica 1989 80 3 287 291 2-s2.0-0024431994 (Pubitemid 19249941)
63. Ferrarese C., Appollonio I., Bianchi G., Frigo M., Marzorati C., Pecora N., Perego M., Pierpaoli C., Frattola L., Benzodiazepine receptors and diazepam binding inhibitor: a possible link between stress, anxiety and the immune system. Psychoneuroendocrinology 1993 18 1 3 22 2-s2.0-0027457549 10.1016/0306-4530(93)90051-L (Pubitemid 23080620)
64. Levy B. H., Tasker J. G., Synaptic regulation of the hypothalamic- pituitary-adrenal axis and its modulation by glucocorticoids and stress. Frontiers in Cellular Neuroscience 2012 6, article 24
65. Taupin V., Herbelin A., Descamps-Latscha B., Zavala F., Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. Lymphokine and Cytokine Research 1991 10 1-2 7 13 2-s2.0-0025910167
66. Morilak D. A., Barrera G., Echevarria D. J., Garcia A. S., Hernandez A., Ma S., Petre C. O., Role of brain norepinephrine in the behavioral response to stress. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005 29 8 1214 1224 2-s2.0-27944444457 10.1016/j.pnpbp.2005.08.007 (Pubitemid 41674636)
67. Johnson J. D., Campisi J., Sharkey C. M., Kennedy S. L., Nickerson M., Greenwood B. N., Fleshner M., Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005 135 4 1295 1307 2-s2.0-26244440570 10.1016/j.neuroscience.2005.06.090 (Pubitemid 41416690)
68. Goddard A. W., Ball S. G., Martinez J., Robinson M. J., Yang C. R., Russell J. M., Shekhar A., Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depression and Anxiety 2010 27 4 339 350 2-s2.0-77953604436 10.1002/da.20642
69. Callado L. F., Meana J. J., Grijalba B., Pazos A., Sastre M., García-Sevilla J. A., Selective increase of α (2A)-adrenoceptor agonist binding sites in brains of depressed suicide victims. Journal of Neurochemistry 1998 70 3 1114 1123 2-s2.0-0031594755 (Pubitemid 28113645)
70. García-Sevilla J. A., Ventayol P., Pérez V., Rubovszky G., Puigdemont D., Ferrer-Alcón M., Andreoli A., Guimón J., Alvarez E., Regulation of platelet α 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment. Neuropsychopharmacology 2004 29 3 580 588 2-s2.0-12144286653 10.1038/sj.npp.1300356 (Pubitemid 38365935)
71. Valdizán E. M., Díez-Alarcia R., González-Maeso J., Pilar-Cuéllar F., García-Sevilla J. A., Meana J. J., Pazos A., α 2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological Psychiatry 2010 68 9 869 872 2-s2.0-77957919737 10.1016/j.biopsych.2010.07.023
72. Ordway G. A., Schenk J., Stockmeier C. A., May W., Klimek V., Elevated agonist binding to α 2-adrenoceptors in the locus coeruleus in major depression. Biological Psychiatry 2003 53 4 315 323 2-s2.0-0037441824 10.1016/S0006-3223(02)01728-6 (Pubitemid 36175545)
73. Maes M., van Gastel A., Delmeire L., Meltzer H. Y., Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine. Biological Psychiatry 1999 45 3 278 284 2-s2.0-0033083149 10.1016/S0006-3223(98)00002-X (Pubitemid 29100031)
74. Marazziti D., Baroni S., Masala I., Di Nasso E., Giannaccini G., Betti L., Lucacchini A., Cassano G. B., Correlation between platelet α 2-adrenoreceptors and symptom severity in major depression. Neuropsychobiology 2001 44 3 122 125 2-s2.0-0035741906 10.1159/000054930 (Pubitemid 34701617)
75. Jann M. W., Slade J. H., Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007 27 11 1571 1587 2-s2.0-35848958367 10.1592/phco.27.11.1571 (Pubitemid 350060211)
76. Sullivan M. D., Robinson J. P., Antidepressant and anticonvulsant medication for chronic pain. Physical Medicine and Rehabilitation Clinics of North America 2006 17 2 381 400 2-s2.0-33645980996 10.1016/j.pmr.2005.12.006
77. Dwyer J. M., Rizzo S. J. S., Neal S. J., Lin Q., Jow F., Arias R. L., Rosenzweig-Lipson S., Dunlop J., Beyer C. E., Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models. Psychopharmacology 2009 203 1 41 52 2-s2.0-60449100825 10.1007/s00213-008-1373-7
78. Kenis G., Maes M., Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 2002 5 4 401 412 2-s2.0-0036901920 10.1017/S1461145702003164 (Pubitemid 35470359)
79. Hernández M. E., Mendieta D., Martínez-Fong D., Loría F., Moreno J., Estrada I., Bojalil R., Pavón L., Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. European Neuropsychopharmacology 2008 18 12 917 924 2-s2.0-53649099619 10.1016/j.euroneuro.2008.08.001
80. Hassel B., Taubøll E., Shaw R., Gjerstad L., Dingledine R., Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin. Epilepsia 2010 51 9 1714 1720 2-s2.0-77956309740 10.1111/j.1528-1167.2010.02545.x
81. Girgenti M. J., Nisenbaum L. K., Bymaster F., Terwilliger R., Duman R. S., Newton S. S., Antipsychotic-induced gene regulation in multiple brain regions. Journal of Neurochemistry 2010 113 1 175 187 2-s2.0-77749295459 10.1111/j.1471-4159.2010.06585.x